Safety and efficacy of atezolizumab in the treatment of cancers: a systematic review and pooled-analysis
Yan Tie,1,2 Hui Yang,1 Rui Zhao,3 Heng Zheng,4 Daoke Yang,5 Jingyi Zhao,5 Ming Liu1,2 1Cancer Center, West China Hospital, Sichuan University, Chengdu, China; 2State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Chi...
Main Authors: | Tie Y, Yang H, Zhao R, Zheng H, Yang D, Zhao J, Liu M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/safety-and-efficacy-of-atezolizumab-in-the-treatment-of-cancers-a-syst-peer-reviewed-article-DDDT |
Similar Items
-
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
by: Arndt Vogel, et al.
Published: (2021-05-01) -
Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
by: Amparo Burgos-San José, et al.
Published: (2021-05-01) -
Pan‐cancer population pharmacokinetics and exposure‐safety and ‐efficacy analyses of atezolizumab in patients with high tumor mutational burden
by: Colby S. Shemesh, et al.
Published: (2020-12-01) -
Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer
by: Colby S. Shemesh, et al.
Published: (2019-11-01) -
A Case of Pseudoprogression During Atezolizumab Therapy
in Lung Adenocarcinoma
by: Xue WANG, et al.
Published: (2019-06-01)